Sexual function of women with breast cancer. Malignant neoplasm of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women with breast cancer after mastectomy Score less than 26.5 of female sexual function index questionnaire Married To have sexual relation with husband To have minimum one child After complete of chemotherapy course Diagnosis of breast cancer 6 month till 5 years before present in research Ability to attend in group therapy session Having at least elementary education Score less than 75 of Larson sexual satisfaction questionnaire Reproductive ages 18-49 years
Exclusion criteria
Exclusion criteria: Pregnancy and lactation Chronic diseases such as hypertension, diabetes and thyroid disease, and autoimmune diseases Menopause Taking antipsychotic drugs during the past 6 months Psychiatric disorders Use of Hormone Replacement Therapy (HRT) Drug addiction or alcohol dependence or psychoactive materials based on personal comments Treatment another type of cancer or malignancy Participate in concurrent therapy programs to reduce sexual problems and reduce other psychological problems The occurrence of a unpleasant event during the last 6 months Hysterectomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function of women with breast cancer. Timepoint: Before the intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Sexual satisfaction. Timepoint: Before the intervention- 8 weeks after intervention. Method of measurement: Larson sexual satisfaction questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sexual desire. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Sexual arousal. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Vaginal Lubrication. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Orgasm. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Dyspareunia. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Sexual pleasure. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences